227 related articles for article (PubMed ID: 18724382)
1. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4.
El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
Br J Pharmacol; 2008 Dec; 155(7):1066-75. PubMed ID: 18724382
[TBL] [Abstract][Full Text] [Related]
2. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
Roch-Ramel F; Guisan B; Diezi J
J Pharmacol Exp Ther; 1997 Feb; 280(2):839-45. PubMed ID: 9023298
[TBL] [Abstract][Full Text] [Related]
3. Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs.
Fanelli GM; Weiner IM
J Clin Invest; 1973 Aug; 52(8):1946-57. PubMed ID: 4719671
[TBL] [Abstract][Full Text] [Related]
4. Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
Shin HJ; Takeda M; Enomoto A; Fujimura M; Miyazaki H; Anzai N; Endou H
Nephrology (Carlton); 2011 Feb; 16(2):156-62. PubMed ID: 21272127
[TBL] [Abstract][Full Text] [Related]
5. [Uricosuric agent].
Ohno I
Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic approach to the maintenance of urate homeostasis.
Kelley WN
Nephron; 1975; 14(1):99-115. PubMed ID: 1091870
[TBL] [Abstract][Full Text] [Related]
7. Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition.
Lin H; Tu C; Niu Y; Li F; Yuan L; Li N; Xu A; Gao L; Li L
Eur J Pharmacol; 2019 Jun; 853():371-380. PubMed ID: 31009635
[TBL] [Abstract][Full Text] [Related]
8. Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4.
Bataille AM; Goldmeyer J; Renfro JL
Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R2024-33. PubMed ID: 18945957
[TBL] [Abstract][Full Text] [Related]
9. Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.
Yu Z; Fong WP; Cheng CH
Drug Metab Dispos; 2007 Jun; 35(6):981-6. PubMed ID: 17325024
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers.
Ng DY; Stocker SL; Graham GG; Williams KM; Day RO
Eur J Clin Pharmacol; 2011 Jul; 67(7):709-13. PubMed ID: 21181139
[TBL] [Abstract][Full Text] [Related]
11. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.
Van Aubel RA; Smeets PH; van den Heuvel JJ; Russel FG
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F327-33. PubMed ID: 15454390
[TBL] [Abstract][Full Text] [Related]
12. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
[TBL] [Abstract][Full Text] [Related]
13. Renal handling of urate in healthy man in hyperuricaemia and renal insufficiency: circadian fluctuation, effect of water diuresis and of uricosuric agents.
Lang F; Greger R; Oberleithner H; Griss E; Lang K; Pastner D; Dittrich P; Deetjen P
Eur J Clin Invest; 1980 Aug; 10(4):285-92. PubMed ID: 6775956
[TBL] [Abstract][Full Text] [Related]
14. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
15. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
16. Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Rheumatology (Oxford); 2012 Sep; 51(9):1670-6. PubMed ID: 22539486
[TBL] [Abstract][Full Text] [Related]
17. Voltage-driven p-aminohippurate, chloride, and urate transport in porcine renal brush-border membrane vesicles.
Krick W; Wolff NA; Burckhardt G
Pflugers Arch; 2000 Nov; 441(1):125-32. PubMed ID: 11205051
[TBL] [Abstract][Full Text] [Related]
18. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
J Pharmacol Exp Ther; 2007 Jan; 320(1):229-35. PubMed ID: 17005917
[TBL] [Abstract][Full Text] [Related]
20. Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.
Shaw MI; Parsons DS
Clin Sci (Lond); 1984 Mar; 66(3):257-67. PubMed ID: 6692658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
